Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
March 31, 2012
Contribution of tumoral and host solute carriers to clinical drug response
Jason A Sprowl, Torben S Mikkelsen, Hugh Giovinazzo, et al.
Frontiers in Nephrology
|
October 4, 2023
Early clinical indicators of acute kidney injury caused by administering high-dose methotrexate therapy to juvenile pigs
Randal K Buddington, Thomas Wong, Karyl K Buddington, et al.
Research and Practice in Thrombosis and Haemostasis
|
February 17, 2023
<i>F8/F9</i> variants in the population-based PedNet Registry cohort compared with locus-specific genetic databases of the European Association for Haemophilia and Allied Disorders and the Centers for Disease Control and Prevention Hemophilia A or Hemophilia B Mutation Project
Veerle Labarque, Maria Elisa Mancuso, Mutlu Kartal-Kaess, et al.
Acta Oncologica (Stockholm, Sweden)
|
May 8, 2024
Treatment-related mortality among children with cancer in Denmark during 2001-2021
Marie C L Sørensen, Mie M Andersen, Klaus Rostgaard, et al.
Pediatric Hematology and Oncology
|
October 22, 2023
Access to Methotrexate Monitoring in Latin America: A Multicountry Survey of Supportive Care Capacity
Gabriela Villanueva, Jennifer Lowe, Nicolás Tentoni, et al.
Journal of Pediatric Hematology/Oncology
|
June 21, 2016
Prophylactic Trimethoprim-Sulfamethoxazole Does Not Affect Pharmacokinetics or Pharmacodynamics of Methotrexate
Courtney S Watts, Joseph N Sciasci, Jennifer L Pauley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2011
Shortening infusion time for high-dose methotrexate alters antileukemic effects: a randomized prospective clinical trial
Torben S Mikkelsen, Alex Sparreboom, Cheng Cheng, et al.
Genome Research
|
December 8, 2011
Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition
Laura B Ramsey, Gitte H Bruun, Wenjian Yang, et al.
Pharmacogenetics and Genomics
|
February 15, 2011
PharmGKB summary: methotrexate pathway
Torben S Mikkelsen, Caroline F Thorn, Jun J Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2012
Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel
Anne-Joy M de Graan, Cynthia S Lancaster, Amanda Obaidat, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
March 31, 2012
Contribution of tumoral and host solute carriers to clinical drug response
Jason A Sprowl, Torben S Mikkelsen, Hugh Giovinazzo, et al.
Frontiers in Nephrology
|
October 4, 2023
Early clinical indicators of acute kidney injury caused by administering high-dose methotrexate therapy to juvenile pigs
Randal K Buddington, Thomas Wong, Karyl K Buddington, et al.
Research and Practice in Thrombosis and Haemostasis
|
February 17, 2023
<i>F8/F9</i> variants in the population-based PedNet Registry cohort compared with locus-specific genetic databases of the European Association for Haemophilia and Allied Disorders and the Centers for Disease Control and Prevention Hemophilia A or Hemophilia B Mutation Project
Veerle Labarque, Maria Elisa Mancuso, Mutlu Kartal-Kaess, et al.
Acta Oncologica (Stockholm, Sweden)
|
May 8, 2024
Treatment-related mortality among children with cancer in Denmark during 2001-2021
Marie C L Sørensen, Mie M Andersen, Klaus Rostgaard, et al.
Pediatric Hematology and Oncology
|
October 22, 2023
Access to Methotrexate Monitoring in Latin America: A Multicountry Survey of Supportive Care Capacity
Gabriela Villanueva, Jennifer Lowe, Nicolás Tentoni, et al.
Journal of Pediatric Hematology/Oncology
|
June 21, 2016
Prophylactic Trimethoprim-Sulfamethoxazole Does Not Affect Pharmacokinetics or Pharmacodynamics of Methotrexate
Courtney S Watts, Joseph N Sciasci, Jennifer L Pauley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2011
Shortening infusion time for high-dose methotrexate alters antileukemic effects: a randomized prospective clinical trial
Torben S Mikkelsen, Alex Sparreboom, Cheng Cheng, et al.
Genome Research
|
December 8, 2011
Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition
Laura B Ramsey, Gitte H Bruun, Wenjian Yang, et al.
Pharmacogenetics and Genomics
|
February 15, 2011
PharmGKB summary: methotrexate pathway
Torben S Mikkelsen, Caroline F Thorn, Jun J Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2012
Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel
Anne-Joy M de Graan, Cynthia S Lancaster, Amanda Obaidat, et al.
Page
of 1